Genta, Inc (fka GNTAQ)

[The Holder]

It's not good news at all...

...it's terrible news. They got denied and anyone who tries to spin this is out of their mind. Period. This is what I was afraid of and it all but puts the final nail in the coffin for Genasense as it relates to CLL. That's a fact (unless someone wants to partner with them specifically for this application). They are not going to scrape the bottom of the barrel for funds to start a new clinical trial (which costs millions of dollars) when the Agenda Trial needs all their focus and money. The CEO said it's their #1 priority.

The Agenda Clinical Trial is a different story and will receive the last dime Genta has in order to be completed end to end.